Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right and therefore also a comorbidity. Globally, there has been a rapid increase in prevalence over the last few decades, with more than one billion people affected by 2024. The obesity epidemic is a phenomenon that is being addressed by national and international cardiology societies in particular and discussed in corresponding consensus statements and guidelines.
Partner
Autoren
- Dr. med. Elisa Alba Schmidt
- PD Dr. med. David Niederseer
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Doing sport without fear or risk
Doing sport without fear or risk
- Chronic inducible urticaria
What has stayed the same, what has changed?
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- Glomerulonephritis: IgA nephropathy
Pathogenesis-based and nephroprotective therapeutic approaches
- Case report: Acute rheumatic fever
ARF with myocarditis and occlusion of the RCA
- Internal thoracoscopy
Diagnostic indications
- Rare pulmonary syndromes